General Information
Version
6.8
Revision date
2024-03-04
Product name
Bucetin
CAS No.
1083-57-4
REACH No
A
Icons in SDS
Company Information
company name
Merck Life Science (Pty) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
Melissa.byrne@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H312, H312+H332, H332, H350
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 4) H332: Harmful if inhaled Acute toxicity, (Category 4) H312: Harmful in contact with skin Carcinogenicity, (Category 1B) H350: May cause cancer
Signal word
Danger Danger
Hazard statements
H312 + H332 Harmful in contact with skin or if inhaled. H350 May cause cancer. H350 May cause cancer.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H332: Harmful if inhaled. Acute toxicity, (Category 4) H312: Harmful in contact with skin. Carcinogenicity, (Category 1B) H350: May cause cancer.
